Advertisement
Advertisement

SLXN

SLXN logo

Silexion Therapeutics Corp Ordinary Shares

2.70
USD
Sponsored
-0.01
-0.37%
Jun 24, 15:55 UTC -4
Closed
exchange

After-Market

2.70

0.00
-0.04%

SLXN Earnings Reports

Positive Surprise Ratio

SLXN beat 3 of 7 last estimates.

43%

Next Report

Date of Next Report
--
Estimate for Q-- -- (Revenue/ EPS)
--
/
--
Implied change from Q1 26 (Revenue/ EPS)
--
/
--
Implied change from Q-- -- (Revenue/ EPS)
--
/
--

Silexion Therapeutics Corp Ordinary Shares earnings per share and revenue

On May 15, 2026, SLXN reported earnings of -8.50 USD per share (EPS) for Q1 26, beating the estimate of -13.15 USD, resulting in a 35.40% surprise. Revenue reached --, compared to an expected --, with a --% difference. The market reacted with a -5.36% price change (close before vs. close after earnings).
Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Vistagen Therapeutics, Inc. Common Stock
Report Date
Jun 15, 2026 For Q4 26
Estimate
-$0.34
Actual
-$0.37
Surprise
-7.75%
logo
enGene Therapeutics Inc. Common Stock
Report Date
Jun 15, 2026 For Q2 26
Estimate
-$0.47
Actual
-$0.43
Surprise
+10.32%
logo
Grace Therapeutics, Inc. Common Stock
Report Date
Jun 18, 2026 For Q4 26
Estimate
-$0.23
Actual
-$0.06
Surprise
+74.42%
FAQ
For Q1 2026, Silexion Therapeutics Corp Ordinary Shares reported EPS of -$8.50, beating estimates by 35.4%, and revenue of --, -- -- expectations.
The stock price moved down -5.36%, changed from $0.29 before the earnings release to $0.27 the day after.
The next earning report is scheduled for --.
Based on -- analysts, Silexion Therapeutics Corp Ordinary Shares is expected to report EPS of -- and revenue of -- for Q-- --.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement